Chinese Journal of Dermatology ›› 2018, Vol. 51 ›› Issue (6): 456-459.doi: 10.3760/cma.j.issn.0412-4030.2018.06.016

Previous Articles     Next Articles

A study on mechanism underlying the inhibition of berberine on proliferation of human melanoma A375 cells

Ren-Min 1,Dong-Xia LI 3, 3   

  • Received:2017-03-27 Revised:2017-12-22 Online:2018-06-15 Published:2018-05-30
  • Contact: Dong-Xia LI E-mail:ldx828@sina.com
  • Supported by:
    Science and Technology Planning Project of Inner Mongolia Autonomous Region;Natural Science Foundation of Inner Mongolia Autonomous Region of China

Abstract: Ren Min, Li Dongxia, Yang Ling, Su Xiulan Department of Dermatology and Venereology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China (Ren M, Li DX); Clinical Medical Research Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China (Yang L, Su XL) Corresponding author: Li Dongxia Email: ldx828@sina.com 【Abstract】 Objective To evaluate the effect of berberine on the of cell cycle-related miRNA and its target gene in human melanoma A375 cells. Methods In vitro cultured A375 cells were classified into several groups to be treated with berberine at different concentrations of 0 (blank control group), 20, 40, 60, 80, and 100 μmol/L, respectively, for 48 hours. qRT-PCR was performed to determine the mRNA of miRNA-582-5p and its target gene cyclin-dependent kinase 1 (CDK1), miRNA-188-5p and its target gene CDK2, Cyclin D1 and Cyclin A. Western blot analysis was conducted to measure the protein of cell cycle-related proteins CDK1, CDK2, Cyclin D1 and Cyclin A. Results qRT-PCR showed that compared with the blank control group, the 20 and 40 μmol/L berberine groups had a similar of miRNA-582-5p (both P > 0.05), but the 60 and 80 μmol/L berberine groups had a significantly up-regulated of miRNA-582-5p (both P < 0.05). Compared with the blank control group, all the 5 berberine groups had a significantly increased of miRNA-188-5p (F = 22.600, P = 0.002). However, the mRNA of CDK2, CDK1, Cyclin A and Cyclin D1 gradually decreased along with the increase of berberine concentrations (F = 51.976, 248.510, 626.671 and 312.740, respectively, all P < 0.001). Western blot analysis revealed that berberine decreased the protein of CDK1, CDK2, Cyclin D1 and Cyclin A (F = 138.124, 110.966, 278.772 and 140.167, all P < 0.001). Conclusion Berberine can decrease the of cell cycle-related proteins CDK1, CDK2, Cyclin D1 and Cyclin A, likely by decreasing their mRNA and increasing the of miRNA-582-5p and miRNA-188-5p, and then block the cell cycle progression of A375 cells and inhibit the growth of tumor.

Key words: Berberine, Melanoma, MicroRNAs, Cyclins, Cyclin-dependent kinases, A375 cells